樂氏同仁藥業科技集團有限公司 v. 中國北京同仁堂(集團)有限責任公司
Read the full judgment text of HCIP 62/2020 on BabelCite. This High Court CFI judgment was delivered on 11 August 2022.
Cited by 1 case · Cites 1 case
|
HCIP 62/2020 [2022] HKCFI 2512 IN THE HIGH COURT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION COURT OF FIRST INSTANCE INTELLECTUAL PROPERTY PROCEEDINGS NO. 62 OF 2020 ________________________
________________________ BETWEEN
AND HCIP 63/2020 IN THE HIGH COURT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION COURT OF FIRST INSTANCE INTELLECTUAL PROPERTY PROCEEDINGS NO. 63 OF 2020 ________________________
________________________ BETWEEN
________________________ (Heard together)
________________________ C O R R I G E N D U M ________________________ Please note the following corrigendum in the Judgment dated 11 August 2022: Paragraph 5 of the Judgment should be replaced by the following:- “For easy reference, I will refer the mark in §3 above as “the Logo Mark” because it contains a logo and the mark in §4 above as “the Words Mark” because it contains only words. I will also refer both marks collectively as “the Subject Marks”.” Dated the 20th day of December 2024
| ||||||||||||||||||||||||||||||||||||||||||
Cases cited in this judgment
Other judgments that cite this case
Further hearings and rulings under HCIP 62/2020
in Classes 3 and 5 (the “Subject Application”/ “Opposed Mark”) applied for by 樂氏同仁藥業科技集團有限公司 (the “Applicant”/ “Appellant”)
in Classes 32, 33, 36 and 41 (the “Subject Application”/ “Opposed Mark”) applied for by 樂氏同仁藥業科技集團有限公司 (the “Applicant”/“Appellant”)